p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 582-587

  Van den Blink, B ^a   Juffermans, N P ^a   Ten Hove, T ^a   Schultz, M J ^a   Van Deventer, S J H ^a   Van der Poll, T ^a   Peppelenbosch, M P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFECTION; LOBAR PNEUMONIA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0035160822     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.582     Document Type: Article

References (24)

1. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
2. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
3. Murine p38-δ mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines
4. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
5. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
6. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
7. Tumour necrosis factor-α-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils
8. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
9. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages
10. A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression
11. Involvement of mitogenactivated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or Mycoplasma fermentans membrane lipoproteins
12. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
13. The role of p38 mitogenactivated protein kinase in IL-1β transcription
14. Mitogenactivated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells: Indications of communication between p38 and p42 MAP kinases
15. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice
16. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses
17. Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways
18. Interieukin-10 impairs host defense in murine pneumococcal pneumonia
19. Compartmentalized cytokine production within the human lung in unilateral pneumonia
20. Macrophages are a significant source of type I cytokines during mycobacterial infection
21. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
22. Activation of p90(RSK) and cAMP response element binding protein in stimulated neutrophils: Novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade
23. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation
24. Cell stress and MKK6bmediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IκB phosphorylation and NF-κB activation